Latest

Latest FDA News | Page 2

  • Latest FDA news stories and updates. What is happening today? All recent FDA news and developments. Live coverage and timeline of FDA. All you need to know about FDA.
US FDA grants Argenica Therapeutics’ ARG-007 orphan drug designation
Neuren Pharmaceuticals completes Phelan-McDermid syndrome Phase 2 trial 
Alzheimer’s lecture focuses on new treatment developments and diagnostics
Student-designed artificial heart pumped to beat world’s best at first ever Heart Hackathon
US Food and Drug Administration accepts for review AstraZeneca’s Supplemental Biologics License Application for self-administration of FluMist Quadrivalent
FDA grants Certa Therapeutics’ FT011 orphan drug designation for systemic sclerosis
FDA funds Australian research for better, affordable asthma inhalers
Tagrisso plus chemotherapy granted Priority Review in the US for patients with EGFR-mutated advanced lung cancer
Finally the answer to the dreaded paper straw
US FDA grants Orphan Drug Designation for Noxopharm’s CRO-67
US FDA grants conditional approval to the brand name of Dimerix’s DMX-200
HealthTech InnovationAus award finalists announced
Australian-developed drug receives US FDA approval
New discovery for treatment of primary liver cancer
What you need to know about COVID, flu and RSV vaccines
Fasenra met the primary endpoint in the MANDARA Phase III trial in eosinophilic granulomatosis with polyangiitis (EGPA)
A tax on menthol cigarettes would work better than statewide bans, UW study finds
Update on US regulatory review of Ultomiris in NMOSD
A prescription product to help people at risk of dying by suicide
Biotron completes clinical phase of BIT225 COVID-19 clinical trial
Imugene licenses allogeneic CAR-T with a potential registration study in 2024
CSL reports strong profit growth with record plasma collections
AusBiotech 2023 Millis Orator announced
Immutep receives positive scientific advice from the European Medicines Agency
H1 and Q2 2023 results
Neuren Pharmaceuticals wins Bioshares Excellence Award
Restoring Lost Sense of Smell
Pharmaxis reports positive analysis of data from phase 2 PXS-5505 study
Lumos completes placement and launches share purchase plan
Moderna submits RSV vaccine to global regulatory agencies
Solar Powered Sunscreen: EcoZinc a World First in Sustainable Zinc Oxide Innovation
Neuren opens first site in US for Prader-Willi syndrome Phase 2 trial
Vague language impacts perceptions of vaping risks, study finds
We are closer than ever to being able to 3D print medicines. Here’s why that’s important
AVITA Medical announces FDA approval of RECELL for skin repigmentation in vitiligo patients
Capivasertib in combination with Faslodex granted Priority Review in the US for patients with advanced HR-positive breast cancer
Nirsevimab unanimously recommended by FDA Advisory Committee for the prevention of RSV lower respiratory tract disease in infants
Neuren Pharmaceuticals receives milestone payment from US partner
Kinoxis awarded new US grant funding to support clinical development of KNX100 for opioid use disorder
Aravax launches new Phase 2 trial of peanut allergy candidate
Optiscan Imaging launches entitlement offer to raise $16.7 million
Q-Gen Cell Therapeutics leading the charge in revolutionary cell therapy research
Energy Breakthrough gets waste wise
The FDA finally approved Elon Musk’s Neuralink chip for human trials. Have all the concerns been addressed?
SCEMBLIX®, A NOVEL TREATMENT, NOW LISTED ON THE PBS FOR ADULT PATIENTS WITH CHRONIC MYELOID LEUKAEMIA
E-cigarette companies seek IP protections in face of rising regulation
Chimeric Therapeutics announces new capital raise
‘We Are So Sick as a Nation’: Food is Medicine Summit Puts Focus on Nutrition

© 2024 - The National Tribune Australia